Therapeutic Asset Ratings
114 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Vyxeos
Leukemia
Children's Hospital Medical Center, Cincinnati
P1
C
(37)
Ziftomenib
Leukemia
Kura Oncology, Inc.
P1
C
(37)
Bisoprolol Fumarate
Leukemia
University of Arizona
Early P1
C
(34)
Bite-Ev
Leukemia
Beijing GoBroad Hospital
Early P1
C
(34)
CARVEDILOL
Leukemia
University of Arizona
Early P1
C
(34)
Isoproterenol
Leukemia
University of Arizona
Early P1
C
(34)
NADOLOL
Leukemia
University of Arizona
Early P1
C
(34)
Roflumilast
Leukemia
University of Arizona
Early P1
C
(34)
Gamma-delta (??) T cells
Leukemia
Guangzhou Bio-gene Technology Co., Ltd
Early P1
C
(33)
6-(4-(1,1-Dimethylethyl)phenoxy)-3-pyridinamine
Leukemia
M.D. Anderson Cancer Center
P2
D
(29)
Rivogenlecleucel
Leukemia
Bellicum Pharmaceuticals
P1
D
(29)
Apixaban
Leukemia
Medical University of Gdansk
N/A
D
(28)
Enoxaparin
Leukemia
Medical University of Gdansk
N/A
D
(28)
Rivaroxaban
Leukemia
Medical University of Gdansk
N/A
D
(28)
Showing 101 to 114 of 114 assets
Previous
Page 5 of 5
Next
